Global Sexually Transmitted Diseases (STD) Testing Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Jan-2020
No. of pages: 94
Inquire Before Buying

This report focuses on the global Sexually Transmitted Diseases (STD) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexually Transmitted Diseases (STD) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- ROCHE HOLDINGS

- BIOMERIEUX

- HOLOGIC

- BECTON DICKINSON

- ORASURE

- DANAHER

- AFFYMETRIX

- ABBOTT LABORATORIES

- BIO-RAD LABORATORIES

- DIASORIN

Market segment by Type, the product can be split into

- Chlamydia

- Syphilis

- Gonorrhea

- Herpes Simplex Virus

- Human Papilloma Virus

- Human Immunodeficiency Virus

- Others

Market segment by Application, split into

- Laboratory Testing

- Point of Care (POC) Testing

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Sexually Transmitted Diseases (STD) Testing status, future forecast, growth opportunity, key market and key players.

- To present the Sexually Transmitted Diseases (STD) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sexually Transmitted Diseases (STD) Testing are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Sexually Transmitted Diseases (STD) Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
1.4 Market Analysis by Type
1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chlamydia
1.4.3 Syphilis
1.4.4 Gonorrhea
1.4.5 Herpes Simplex Virus
1.4.6 Human Papilloma Virus
1.4.7 Human Immunodeficiency Virus
1.4.8 Others
1.5 Market by Application
1.5.1 Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2026
1.5.2 Laboratory Testing
1.5.3 Point of Care (POC) Testing
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Sexually Transmitted Diseases (STD) Testing Market Perspective (2015-2026)
2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Regions
2.2.1 Sexually Transmitted Diseases (STD) Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Share by Regions (2015-2020)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Sexually Transmitted Diseases (STD) Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Sexually Transmitted Diseases (STD) Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Market Size
3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2015-2020)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2019
3.3 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
3.4 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
3.5 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2015-2020)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2021-2026)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application (2015-2026)
5.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
6.2 Sexually Transmitted Diseases (STD) Testing Key Players in North America (2019-2020)
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
7.2 Sexually Transmitted Diseases (STD) Testing Key Players in Europe (2019-2020)
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
8 China
8.1 China Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
8.2 Sexually Transmitted Diseases (STD) Testing Key Players in China (2019-2020)
8.3 China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
8.4 China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
9.2 Sexually Transmitted Diseases (STD) Testing Key Players in Japan (2019-2020)
9.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
9.4 Japan Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
10.2 Sexually Transmitted Diseases (STD) Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
11 India
11.1 India Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
11.2 Sexually Transmitted Diseases (STD) Testing Key Players in India (2019-2020)
11.3 India Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
11.4 India Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size (2015-2020)
12.2 Sexually Transmitted Diseases (STD) Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020)
12.4 Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020)
13Key Players Profiles
13.1 ROCHE HOLDINGS
13.1.1 ROCHE HOLDINGS Company Details
13.1.2 ROCHE HOLDINGS Business Overview and Its Total Revenue
13.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
13.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020))
13.1.5 ROCHE HOLDINGS Recent Development
13.2 BIOMERIEUX
13.2.1 BIOMERIEUX Company Details
13.2.2 BIOMERIEUX Business Overview and Its Total Revenue
13.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
13.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.2.5 BIOMERIEUX Recent Development
13.3 HOLOGIC
13.3.1 HOLOGIC Company Details
13.3.2 HOLOGIC Business Overview and Its Total Revenue
13.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
13.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.3.5 HOLOGIC Recent Development
13.4 BECTON DICKINSON
13.4.1 BECTON DICKINSON Company Details
13.4.2 BECTON DICKINSON Business Overview and Its Total Revenue
13.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
13.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.4.5 BECTON DICKINSON Recent Development
13.5 ORASURE
13.5.1 ORASURE Company Details
13.5.2 ORASURE Business Overview and Its Total Revenue
13.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
13.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.5.5 ORASURE Recent Development
13.6 DANAHER
13.6.1 DANAHER Company Details
13.6.2 DANAHER Business Overview and Its Total Revenue
13.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
13.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.6.5 DANAHER Recent Development
13.7 AFFYMETRIX
13.7.1 AFFYMETRIX Company Details
13.7.2 AFFYMETRIX Business Overview and Its Total Revenue
13.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
13.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.7.5 AFFYMETRIX Recent Development
13.8 ABBOTT LABORATORIES
13.8.1 ABBOTT LABORATORIES Company Details
13.8.2 ABBOTT LABORATORIES Business Overview and Its Total Revenue
13.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
13.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.8.5 ABBOTT LABORATORIES Recent Development
13.9 BIO-RAD LABORATORIES
13.9.1 BIO-RAD LABORATORIES Company Details
13.9.2 BIO-RAD LABORATORIES Business Overview and Its Total Revenue
13.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
13.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.9.5 BIO-RAD LABORATORIES Recent Development
13.10 DIASORIN
13.10.1 DIASORIN Company Details
13.10.2 DIASORIN Business Overview and Its Total Revenue
13.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
13.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
13.10.5 DIASORIN Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Sexually Transmitted Diseases (STD) Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
Table 3. Ranking of Global Top Sexually Transmitted Diseases (STD) Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chlamydia
Table 6. Key Players of Syphilis
Table 7. Key Players of Gonorrhea
Table 8. Key Players of Herpes Simplex Virus
Table 9. Key Players of Human Papilloma Virus
Table 10. Key Players of Human Immunodeficiency Virus
Table 11. Key Players of Others
Table 12. Global Sexually Transmitted Diseases (STD) Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Sexually Transmitted Diseases (STD) Testing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2015-2020)
Table 16. Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Sexually Transmitted Diseases (STD) Testing Market Growth Strategy
Table 22. Main Points Interviewed from Key Sexually Transmitted Diseases (STD) Testing Players
Table 23. Global Sexually Transmitted Diseases (STD) Testing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players (2015-2020)
Table 25. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2019)
Table 26. Global Sexually Transmitted Diseases (STD) Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
Table 29. Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Type (2015-2020)
Table 33. Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Type (2021-2026)
Table 34. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application (2015-2020)
Table 35. Global Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Sexually Transmitted Diseases (STD) Testing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 39. North America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 41. North America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 43. Europe Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 45. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 47. Europe Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 49. China Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 51. China Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 52. China Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 53. China Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 54. China Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 55. Japan Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 57. Japan Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 59. Japan Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 63. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 65. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 67. India Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 69. India Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 70. India Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 71. India Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 72. India Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Sexually Transmitted Diseases (STD) Testing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Sexually Transmitted Diseases (STD) Testing Market Share (2019-2020)
Table 75. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Sexually Transmitted Diseases (STD) Testing Market Share by Type (2015-2020)
Table 77. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Sexually Transmitted Diseases (STD) Testing Market Share by Application (2015-2020)
Table 79. ROCHE HOLDINGS Company Details
Table 80. ROCHE HOLDINGS Business Overview
Table 81. ROCHE HOLDINGS Product
Table 82. ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 83. ROCHE HOLDINGS Recent Development
Table 84. BIOMERIEUX Company Details
Table 85. BIOMERIEUX Business Overview
Table 86. BIOMERIEUX Product
Table 87. BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 88. BIOMERIEUX Recent Development
Table 89. HOLOGIC Company Details
Table 90. HOLOGIC Business Overview
Table 91. HOLOGIC Product
Table 92. HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 93. HOLOGIC Recent Development
Table 94. BECTON DICKINSON Company Details
Table 95. BECTON DICKINSON Business Overview
Table 96. BECTON DICKINSON Product
Table 97. BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 98. BECTON DICKINSON Recent Development
Table 99. ORASURE Company Details
Table 100. ORASURE Business Overview
Table 101. ORASURE Product
Table 102. ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 103. ORASURE Recent Development
Table 104. DANAHER Company Details
Table 105. DANAHER Business Overview
Table 106. DANAHER Product
Table 107. DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 108. DANAHER Recent Development
Table 109. AFFYMETRIX Company Details
Table 110. AFFYMETRIX Business Overview
Table 111. AFFYMETRIX Product
Table 112. AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 113. AFFYMETRIX Recent Development
Table 114. ABBOTT LABORATORIES Business Overview
Table 115. ABBOTT LABORATORIES Product
Table 116. ABBOTT LABORATORIES Company Details
Table 117. ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 118. ABBOTT LABORATORIES Recent Development
Table 119. BIO-RAD LABORATORIES Company Details
Table 120. BIO-RAD LABORATORIES Business Overview
Table 121. BIO-RAD LABORATORIES Product
Table 122. BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 123. BIO-RAD LABORATORIES Recent Development
Table 124. DIASORIN Company Details
Table 125. DIASORIN Business Overview
Table 126. DIASORIN Product
Table 127. DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2015-2020) (Million US$)
Table 128. DIASORIN Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sexually Transmitted Diseases (STD) Testing Market Share by Type: 2020 VS 2026
Figure 2. Chlamydia Features
Figure 3. Syphilis Features
Figure 4. Gonorrhea Features
Figure 5. Herpes Simplex Virus Features
Figure 6. Human Papilloma Virus Features
Figure 7. Human Immunodeficiency Virus Features
Figure 8. Others Features
Figure 9. Global Sexually Transmitted Diseases (STD) Testing Market Share by Application: 2020 VS 2026
Figure 10. Laboratory Testing Case Studies
Figure 11. Point of Care (POC) Testing Case Studies
Figure 12. Sexually Transmitted Diseases (STD) Testing Report Years Considered
Figure 13. Global Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Sexually Transmitted Diseases (STD) Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Sexually Transmitted Diseases (STD) Testing Market Share by Players in 2019
Figure 18. Global Top Sexually Transmitted Diseases (STD) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Diseases (STD) Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2019
Figure 20. North America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Sexually Transmitted Diseases (STD) Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. ROCHE HOLDINGS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ROCHE HOLDINGS Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 29. BIOMERIEUX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BIOMERIEUX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 31. HOLOGIC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. HOLOGIC Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 33. BECTON DICKINSON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. BECTON DICKINSON Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 35. ORASURE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. ORASURE Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 37. DANAHER Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. DANAHER Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 39. AFFYMETRIX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. AFFYMETRIX Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 41. ABBOTT LABORATORIES Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. ABBOTT LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 43. BIO-RAD LABORATORIES Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. BIO-RAD LABORATORIES Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 45. DIASORIN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. DIASORIN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Testing Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs